Indivior



Ebit Cambiamento Data
AstraZeneca USD 4.2B 119M 2024-12
Eli Lilly USD 5.63B 3.88B 2024-12
Glaxosmithkline GBP 1.83B 1.76B 2024-12
Halozyme Therapeutics USD 182.75M 19.56M 2024-12
Indivior 101M 92M 2024-12
J&J USD 7.39B 2.04B 2025-03
Kyowa Hakko Kirin JPY 29.15B 10.86B 2024-06
Merck USD 5.22B 339M 2024-12
Novartis USD 4.86B 286M 2024-12
Pfizer USD 4.62B 2.42B 2024-12
Sanofi EUR 2.22B 2.84B 2024-12
Supernus Pharmaceuticals USD 48.3M 19.4M 2024-12



Indivior - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.